158 related articles for article (PubMed ID: 33245955)
1. Investigating the performance of a novel pH and cathepsin B sensitive, stimulus-responsive nanoparticle for optimised sonodynamic therapy in prostate cancer.
Hadi MM; Nesbitt H; Masood H; Sciscione F; Patel S; Ramesh BS; Emberton M; Callan JF; MacRobert A; McHale AP; Nomikou N
J Control Release; 2021 Jan; 329():76-86. PubMed ID: 33245955
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma.
Hadi MM; Farrell S; Nesbitt H; Thomas K; Kubajewska I; Ng A; Masood H; Patel S; Sciscione F; Davidson B; Callan JF; MacRobert AJ; McHale AP; Nomikou N
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5007-5023. PubMed ID: 36319895
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin B-degradable, NIR-responsive nanoparticulate platform for target-specific cancer therapy.
Tarassoli SP; de Pinillos Bayona AM; Pye H; Mosse CA; Callan JF; MacRobert A; McHale AP; Nomikou N
Nanotechnology; 2017 Feb; 28(5):055101. PubMed ID: 28029105
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
[TBL] [Abstract][Full Text] [Related]
5. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
6. Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer.
Nicholas D; Nesbitt H; Farrell S; Logan K; McMullin E; Gillan T; Kelly P; O'Rourke D; Porter S; Thomas K; O'Hagan BMG; Nomikou N; Callan B; Callan JF; McHale AP
Eur J Pharm Biopharm; 2021 Jun; 163():49-59. PubMed ID: 33798727
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
Shenoy D; Little S; Langer R; Amiji M
Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488
[TBL] [Abstract][Full Text] [Related]
8. pH-Responsive Nanoparticles for Enhanced Antitumor Activity by High-Intensity Focused Ultrasound Therapy Combined with Sonodynamic Therapy.
Gao H; Wang Z; Tan M; Liu W; Zhang L; Huang J; Cao Y; Li P; Wang Z; Wen J; Shang T; Ran H
Int J Nanomedicine; 2022; 17():333-350. PubMed ID: 35115772
[TBL] [Abstract][Full Text] [Related]
9. Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle.
McEwan C; Kamila S; Owen J; Nesbitt H; Callan B; Borden M; Nomikou N; Hamoudi RA; Taylor MA; Stride E; McHale AP; Callan JF
Biomaterials; 2016 Feb; 80():20-32. PubMed ID: 26702983
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
Devalapally H; Shenoy D; Little S; Langer R; Amiji M
Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
[TBL] [Abstract][Full Text] [Related]
11. Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.
Podgorski I; Linebaugh BE; Sameni M; Jedeszko C; Bhagat S; Cher ML; Sloane BF
Neoplasia; 2005 Mar; 7(3):207-23. PubMed ID: 15799821
[TBL] [Abstract][Full Text] [Related]
12. A versatile, stimulus-responsive nanoparticle-based platform for use in both sonodynamic and photodynamic cancer therapy.
Nomikou N; Curtis K; McEwan C; O'Hagan BMG; Callan B; Callan JF; McHale AP
Acta Biomater; 2017 Feb; 49():414-421. PubMed ID: 27856283
[TBL] [Abstract][Full Text] [Related]
13. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
[TBL] [Abstract][Full Text] [Related]
14. Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2019 Apr; 45(4):532-547. PubMed ID: 30582382
[TBL] [Abstract][Full Text] [Related]
15. Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation.
Zhu P; Chen Y; Shi J
ACS Nano; 2018 Apr; 12(4):3780-3795. PubMed ID: 29613770
[TBL] [Abstract][Full Text] [Related]
16. ROS-augmented and tumor-microenvironment responsive biodegradable nanoplatform for enhancing chemo-sonodynamic therapy.
An J; Hu YG; Cheng K; Li C; Hou XL; Wang GL; Zhang XS; Liu B; Zhao YD; Zhang MZ
Biomaterials; 2020 Mar; 234():119761. PubMed ID: 31954230
[TBL] [Abstract][Full Text] [Related]
17. MRI tracing non-invasive TiO
Yuan P; Song D
Nanotechnology; 2018 Mar; 29(12):125101. PubMed ID: 29350186
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery.
Lee SJ; Jeong YI; Park HK; Kang DH; Oh JS; Lee SG; Lee HC
Int J Nanomedicine; 2015; 10():5489-503. PubMed ID: 26357473
[TBL] [Abstract][Full Text] [Related]
19. Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property.
Wang X; Gu Y; Li Q; Xu Y; Shi Y; Wang Z; Xia M; Li J; Wang D
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112164. PubMed ID: 34735859
[TBL] [Abstract][Full Text] [Related]
20. Crosslinked self-assembled nanoparticles for chemo-sonodynamic combination therapy favoring antitumor, antimetastasis management and immune responses.
Liu M; Khan AR; Ji J; Lin G; Zhao X; Zhai G
J Control Release; 2018 Nov; 290():150-164. PubMed ID: 30308258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
